Five-Year Strategy Lab

Five-year strategy & visioning workspace · FY 2026-27

Five-Year Strategy Lab

Turns the literature review and portfolio data into strategic scenarios: deepen nutrition rights, scale Nutrition Smart Villages, strengthen water resilience, expand eco-food markets and digitise partner monitoring.

AI strategy bets

Each bet carries evidence strength, risk, the data it requires and the next decision for the board

Synthetic demo data

Digitise rights & convergence monitoring

Strong evidenceMedium risk

Required data: CSC scores, scheme access logs

Approve common rights data model for FY26-27

Scale Nutrition Smart Village digital twins

Moderate evidenceMedium risk

Required data: Household profiles, child growth, diet diversity

Fund rollout from 512 → 670 villages

Standardise partner data models

Emerging evidenceHigh risk

Required data: Partner reporting formats inventory

Mandate shared indicators across 30+ partners

Build Bhoomi Ka market intelligence

Moderate evidenceMedium risk

Required data: FPO sales, PGS status, buyer pipeline

Invest in eco-food market dashboard

Strengthen Jal Saheli water governance evidence

Strong evidenceLow risk

Required data: Water body register, before/after assets

Lock WASH evidence pack methodology

Create donor-ready evidence & learning packs

Strong evidenceLow risk

Required data: Evaluations, consented stories, citations

Adopt evidence-pack automation workflow

Strategy Synthesis Agent — five-year priority synthesis

Prioritise digital rights & convergence monitoring and Nutrition Smart Village digital twins as the two highest-confidence bets. Partner data standardisation is the binding constraint: until shared indicators exist across 30+ partners, systemic-outcome claims will remain weak. Sequence Bhoomi Ka market intelligence and Jal Saheli evidence packs to unlock EU and Viva con Agua reporting.

Confidence88%
Evidence completeness67%
Sources:Portfolio dataFHFI evaluationNSV e-zineResearch brief
Assumes current partner reporting can be standardised within FY26-27; 2 bets remain evidence-emerging.
Human review required before use